Netherlands vs Saudi Arabia: Treatment success rate for patients treated for MDR-TB
Netherlands
91.0%
in 2021
Saudi Arabia
93.0%
in 2022
Netherlands rank
21st
Saudi Arabia rank
20th
Treatment success rate for patients treated for MDR-TB over time
- Netherlands
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 91.0% in Netherlands, a difference of 2.0%.
The two have swapped places 2 times across 11 shared years of data; in 2007 it was Netherlands ahead.
Netherlands ranks 21st and Saudi Arabia ranks 20th of 163 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.0% | 38.0% | 42.0% | Netherlands |
| 2010s | 77.3% | 59.4% | 17.9% | Netherlands |
| 2020s | 95.5% | 75.0% | 20.5% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Netherlands or Saudi Arabia?
- Saudi Arabia, at 93.0% against 91.0% in Netherlands as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Netherlands and Saudi Arabia?
- 2.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Netherlands and Saudi Arabia?
- 11 years are reported by both, from 2007 to 2021.
- How do Netherlands and Saudi Arabia rank globally for treatment success rate for patients treated for mdr-tb?
- Netherlands ranks 21st and Saudi Arabia ranks 20th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.